Your browser doesn't support javascript.
loading
Mini Review: The Last Mile-Opportunities and Challenges for Machine Learning in Digital Toxicologic Pathology.
Turner, Oliver C; Knight, Brian; Zuraw, Aleksandra; Litjens, Geert; Rudmann, Daniel G.
Afiliação
  • Turner OC; Novartis, 98557Novartis Institutes for BioMedical Research, Preclinical Safety, East Hanover, NJ, USA.
  • Knight B; 435339Boehringer Ingelheim Pharmaceuticals Incorporated, Nonclinical Drug Safety, Ridgefield, CT, USA.
  • Zuraw A; 25913Charles River Laboratories, Pathology, Frederick, MD, USA.
  • Litjens G; Diagnostic Image Analysis Group Radboud University Medical Center Nijmegen, the Netherlands.
  • Rudmann DG; Charles River Laboratories, Pathology, Ashland, OH, USA.
Toxicol Pathol ; 49(4): 714-719, 2021 06.
Article em En | MEDLINE | ID: mdl-33590805
ABSTRACT
The 2019 manuscript by the Special Interest Group on Digital Pathology and Image Analysis of the Society of Toxicologic pathology suggested that a synergism between artificial intelligence (AI) and machine learning (ML) technologies and digital toxicologic pathology would improve the daily workflow and future impact of toxicologic pathologists globally. Now 2 years later, the authors of this review consider whether, in their opinion, there is any evidence that supports that thesis. Specifically, we consider the opportunities and challenges for applying ML (the study of computer algorithms that are able to learn from example data and extrapolate the learned information to unseen data) algorithms in toxicologic pathology and how regulatory bodies are navigating this rapidly evolving field. Although we see similarities with the "Last Mile" metaphor, the weight of evidence suggests that toxicologic pathologists should approach ML with an equal dose of skepticism and enthusiasm. There are increasing opportunities for impact in our field that leave the authors cautiously excited and optimistic. Toxicologic pathologists have the opportunity to critically evaluate ML applications with a "call-to-arms" mentality. Why should we be late adopters? There is ample evidence to encourage engagement, growth, and leadership in this field.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Patologia / Inteligência Artificial Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Patologia / Inteligência Artificial Idioma: En Ano de publicação: 2021 Tipo de documento: Article